Meta-analysis finds R1 vascular margin acceptable for HCC but not CLM in minimally invasive liver surgery
Tumor margin choice matters differently for liver cancer types
This meta-analysis of 839 patients undergoing minimally invasive liver surgery found that R1 vascular margin (R1v) hepatectomy yields local …
For liver cancer, leaving a narrow margin is safe. For colorectal metastases, it raises recurrence risk.
SBRT with ≥70 Gy BED10 for colorectal liver metastases shows 74.5% 1-year FFLP
Can a higher radiation dose improve tumor control in liver metastases?
This retrospective cohort study of 116 patients with colorectal liver metastases treated with stereotactic body radiation therapy (SBRT) fou…
For liver cancer spread from colorectal cancer, higher radiation doses to tumors significantly lower the risk of regrowth, while multiple tu…
Minimally invasive surgical thermal ablation shows improved technical success and safety in liver malignancy patients
Minimally invasive surgery offers safe, effective treatment for liver cancer tumors
This systematic review and meta-analysis evaluated 3983 patients with hepatocellular carcinoma or colorectal liver metastases treated with m…
Minimally invasive surgery safely destroys liver cancer tumors with just 1% failure rate and 0.25% death risk for patients who can't have fu…
Research across Liver Metastases
Related studies from across the Liver Metastases family.
Serplulimab with FOLFOX showed disease control in AFP-producing gastric adenocarcinoma with liver metastases
Rare Stomach Cancer Shrinks After New Combo Treatment
This case report and literature review describes a 67-year-old man with AFP-producing gastric adenocarcinoma and liver metastases treated wi…
A rare stomach cancer that spread to the liver shrank dramatically when doctors combined standard chemotherapy with a newer immune-boosting …
Robotic simultaneous resection for synchronous colorectal cancer and liver metastases shows feasibility and safety in a meta-analysis
Robots Are Removing Colon Cancer and Liver Tumors in One Operation
This single-arm meta-analysis included 165 patients aged 18 or older with synchronous colorectal cancer and liver metastases.
Robotic surgery safely removes colon cancer and liver tumors in one operation, sparing some patients a second major procedure.
Phase II RCT finds no OS benefit for hepatectomy in colorectal cancer with liver and lung metastases
Does removing liver tumors help when lung tumors remain? A small trial offers mixed answers
A phase II randomized trial in 27 patients with colorectal adenocarcinoma and resectable liver/unresectable lung metastases compared hepatec…
A small trial stopped early found no survival benefit for liver surgery when lung tumors remain, yet patients who actually got the operation…
Questions about colorectal liver metastases
Are R1 vascular margins safe for colorectal liver metastases compared to other liver surgeries?
R1 vascular margins are not considered safe for colorectal liver metastases, as they are linked to higher local recurrence rates compared to R0 resections.
Full answer →Can stereotactic body radiation therapy be used to treat colorectal liver metastases effectively?
Stereotactic body radiation therapy (SBRT) is an effective, non-invasive treatment for colorectal liver metastases, offering high local control rates and serving as an option for patients who cannot undergo surgery.
Full answer →Does minimally invasive surgical thermal ablation improve safety for patients with colorectal liver metastases?
Yes, minimally invasive surgical thermal ablation (MITA) improves safety for colorectal liver metastases, with low major complication rates and very low mortality.
Full answer →Is an R1 vascular margin acceptable for colorectal liver metastases in minimally invasive surgery?
No, an R1 vascular margin is not considered acceptable for colorectal liver metastases in minimally invasive surgery due to higher local recurrence rates compared to R0 resection.
Full answer →